Dehydroandrographoline

CAS: 134418-28-3

Ref. 3D-FD11384

Produktinformation

• Name: Dehydroandrographoline
• Synonyme: Dehydroandrographolide, (2R,5R,10R)-2,17-dihydroxy-20-oxo-9,19-didehydro-5,6,7,8,9,10,15-octahydro-20:5,10-dicycloretinal, (3E)-3-[2-[(1S,4aS,5R,6R,8aS)-Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]-2(3H)-furanone, 14-(P), 14-Deoxy-11-dehydroandrographolide, 2(3H)-Furanone, 3-[2-[(1S,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]-, (3E)-, 2(3H)-Furanone, 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]-, [1R-[1α,2α,4aα,5β(E),8aβ]]-, DEOXY-11,12-DiDehydroandrographolide, Dehydroanddrographolide, andrographolide, Dehydro-

Beschreibung

Dehydroandrographolide is a natural product that has been used in traditional medicine to treat bowel disease, diabetes, and cancer. This compound is found in the plant Andrographis paniculata and has been shown to inhibit P-glycoprotein (P-gp) efflux transporter activity. Dehydroandrographolide also induces autophagy, which is the process by which cells degrade their own components under conditions of nutrient starvation or other stress. In addition, dehydroandrographolide succinate inhibits potassium channel activity and may be a potential anticancer agent. The analytical method for dehydroandrographolide succinate is based on an acid hydrolysis followed by high performance liquid chromatography with UV detection at λ max 218 nm.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 348.43 g/mol
• Formel: C₂₀H₂₈O₅
• Reinheit: Min. 95%
• Farbe/Form: White Powder